{"id":"https://openalex.org/W2137805490","doi":"https://doi.org/10.2174/138920006776873490","title":"Investigation of Exenatide Elimination and Its In Vivo and In Vitro Degradation","display_name":"Investigation of Exenatide Elimination and Its In Vivo and In Vitro Degradation","alternate_titles":[],"publication_year":2006,"publication_date":"2006-04-28","ids":{"openalex":"https://openalex.org/W2137805490","doi":"https://doi.org/10.2174/138920006776873490","mag":"2137805490","pmid":"https://pubmed.ncbi.nlm.nih.gov/16724926"},"language":"en","primary_location":{"id":"doi:10.2174/138920006776873490","doi":"https://doi.org/10.2174/138920006776873490","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138920006776873490","pdf_url":null,"source":{"id":"https://openalex.org/S195680726","display_name":"Current Drug Metabolism","issn_l":"1389-2002","issn":["1389-2002","1875-5453"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2137805490"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039825706","display_name":"Kathrin Copley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathrin Copley","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc. 9360 Towne Centre Dr, Ste 110, San Diego, CA 92121, USA. KCopley@amylin.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc. 9360 Towne Centre Dr, Ste 110, San Diego, CA 92121, USA. KCopley@amylin.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091293213","display_name":"Kevin M. McCowen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin McCowen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079734406","display_name":"Richard Hiles","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Hiles","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075068030","display_name":"Loretta L. Nielsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Loretta Nielsen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024629053","display_name":"Andrew John Young","orcid":"https://orcid.org/0000-0001-6251-0944","observed_orcids":["https://orcid.org/0000-0001-6251-0944"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Young","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5077809872","display_name":"David G. Parkes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Parkes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3222,"has_fulltext":false,"cited_by_count":106,"citation_normalized_percentile":{"value":0.88171755,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"7","issue":"4","first_page":"367","last_page":"374"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":1.0},{"id":"https://openalex.org/keywords/incretin-mimetics","display_name":"incretin mimetics","score":0.6830000281333923},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7760000228881836},{"id":"https://openalex.org/keywords/renal-excretion","display_name":"renal excretion","score":0.6000000238418579},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6909999847412109},{"id":"https://openalex.org/keywords/liver-dysfunction","display_name":"liver dysfunction","score":0.8550000190734863},{"id":"https://openalex.org/keywords/species-differences-in-drug-metabolism","display_name":"species differences in drug metabolism","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9929282069206238},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6786000728607178},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.5474532246589661},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5396544933319092},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46839165687561035},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4483078718185425},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4412262439727783},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4031367599964142},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.278520405292511},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25429823994636536},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21558547019958496},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.19152075052261353},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.17297214269638062},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002853","descriptor_name":"Chromatography, Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005688","descriptor_name":"Galactosamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008103","descriptor_name":"Liver Cirrhosis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008103","descriptor_name":"Liver Cirrhosis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008815","descriptor_name":"Mice, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013853","descriptor_name":"Thioacetamide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/138920006776873490","doi":"https://doi.org/10.2174/138920006776873490","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138920006776873490","pdf_url":null,"source":{"id":"https://openalex.org/S195680726","display_name":"Current Drug Metabolism","issn_l":"1389-2002","issn":["1389-2002","1875-5453"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Metabolism","raw_type":"journal-article"},{"id":"pmid:16724926","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16724926","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current drug metabolism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2236623547","https://openalex.org/W1967331905","https://openalex.org/W1999278306","https://openalex.org/W1995900793","https://openalex.org/W2178262235","https://openalex.org/W1978279496","https://openalex.org/W2001097346","https://openalex.org/W4314434819"],"abstract_inverted_index":{"Exenatide":[0,23,166,208,226],"is":[1,24],"a":[2,25],"39":[3],"amino":[4,117],"acid":[5],"incretin":[6],"mimetic":[7],"for":[8,28],"the":[9,29,56,63,68,157,177,181,236,243,248],"treatment":[10],"of":[11,32,59,71,107,138,180,186,251,255],"type":[12],"2":[13],"diabetes,":[14],"with":[15,235],"glucoregulatory":[16],"activity":[17,233],"similar":[18],"to":[19,49,54,92,222,246],"glucagon-like":[20],"peptide-1":[21],"(GLP-1).":[22],"poor":[26],"substrate":[27],"major":[30,57],"route":[31,58,250],"GLP-1":[33],"degradation":[34,73,100,140,188,254],"by":[35,130,141,176,189],"dipeptidyl":[36],"peptidase-IV,":[37],"and":[38,42,74,76,85,99,122,150,155,164,192,205,212,228,253],"displays":[39],"enhanced":[40],"pharmacokinetics":[41],"in":[43,46,62,87,104,196,224],"vivo":[44],"potency":[45],"rats":[47],"relative":[48],"GLP-1.":[50],"The":[51,134,184],"kidney":[52,132,143,178,194,244],"appears":[53,245],"be":[55,247],"exenatide":[60,72,81,97,127,139,187,223,239],"elimination":[61,98,252],"rat.":[64],"We":[65],"further":[66],"investigated":[67],"putative":[69],"sites":[70,115,137,160],"excretion,":[75],"identified":[77,125],"primary":[78,113,135,158,249],"degradants.":[79],"Plasma":[80],"concentrations":[82],"were":[83,124,145,161,198,214],"elevated":[84],"sustained":[86],"renal-ligated":[88],"rats,":[89],"when":[90,126],"compared":[91,234],"sham-operated":[93],"controls.":[94],"By":[95],"contrast,":[96],"was":[101,128,167],"not":[102,215],"affected":[103],"rat":[105,142,206],"models":[106],"hepatic":[108],"dysfunction.":[109],"In":[110,152,241],"vitro,":[111],"four":[112],"cleavage":[114,136,159],"after":[116,146,162],"acids":[118],"(AA)-15,":[119],"-21,":[120,149],"-22":[121],"-34":[123],"degraded":[129,170],"mouse":[131,204],"membranes.":[133,207],"membranes":[144,179,195],"AA-14,":[147],"-15,":[148],"-22.":[151,165],"rabbit,":[153,190],"monkey,":[154],"human,":[156],"AA-21":[163],"almost":[168],"completely":[169],"into":[171],"peptide":[172],"fragments":[173],"<3":[174],"AA":[175],"species":[182],"tested.":[183],"rates":[185],"monkey":[191],"human":[193],"vitro":[197],"at":[199],"least":[200],"15-fold":[201],"slower":[202],"than":[203],"(1-14),":[209],"(1-15),":[210],"(1-22),":[211],"(23-39)":[213],"active":[216],"as":[217],"either":[218],"agonists":[219],"or":[220],"antagonists":[221],"vitro.":[225],"(15-39)":[227],"(16-39)":[229],"had":[230],"moderate-to-weak":[231],"antagonist":[232],"known":[237],"antagonist,":[238],"(9-39).":[240],"conclusion,":[242],"exenatide.":[256]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2137805490","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
